BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 237089)

  • 1. Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats.
    Braestrup C; Nielsen M
    J Pharm Pharmacol; 1975 Jun; 27(6):413-9. PubMed ID: 237089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for the assay of conjugated 3,4-dihydroxyphenylglycol, a major noradrenaline metabolite in the rat brain.
    Nielsen M; Braestrup C
    J Neurochem; 1976 Nov; 27(5):1211-7. PubMed ID: 12170609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuronal and extraneuronal uptake and metabolism of 3H-(-)-noradrenaline in the perfused rat heart.
    Fiebig ER; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 303(1):21-35. PubMed ID: 673014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat.
    Farah MB; Adler-Graschinsky E; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):119-31. PubMed ID: 585416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of piribedil on noradrenaline and MOPEG-SO4 levels in the rat brain.
    Garattini S; Bareggi SR; Marc V; Calderini G; Morselli PL
    Eur J Pharmacol; 1974 Sep; 28(1):214-6. PubMed ID: 4430323
    [No Abstract]   [Full Text] [Related]  

  • 6. Short and long-term effects of reserpine on the concentration of 1-(4-hydroxy-3-methoxyphenyl)-ethane-1,2-diol (MOPEG-SO4) in the brain of the rat.
    Bareggi SR; Genovese E; Markey K
    Br J Pharmacol; 1979 Apr; 65(4):573-8. PubMed ID: 435682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of normetanephrine, 3,4-dihydroxyphenylethyleneglycol (free and total), and 3-methoxy-4-hydroxyphenylethyleneglycol (free and total) in rat brain by high-performance liquid chromatography with electrochemical detection and effects of drugs on regional concentrations.
    Westerink BH
    J Neurochem; 1984 Apr; 42(4):934-42. PubMed ID: 6699645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation in the central norepinephrine neurotransmission induced in vivo by alpha adrenoceptor active drugs.
    Braestrup C; Nielsen M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):596-608. PubMed ID: 185355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the metabolism of catecholamines in the central nervous system of the mouse.
    Ceasar PM; Hague P; Sharman DF; Werdinius B
    Br J Pharmacol; 1974 Jun; 51(2):187-95. PubMed ID: 4141637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

  • 11. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary 3-methoxy-4-hydroxyphenylglycol production in mice and rats following intraventricular 6-hydroxydopamine.
    Howlett DR; Jenner FA; Nahorski SR
    J Pharm Pharmacol; 1975 Jun; 27(6):447-9. PubMed ID: 237098
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG).
    Keeton TK; Krutzsch H; Lovenberg W
    Science; 1981 Feb; 211(4482):586-8. PubMed ID: 7455697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites.
    Muldoon SM; Vanhoutte PM; Tyce GM
    Am J Physiol; 1978 Mar; 234(3):H235-43. PubMed ID: 629360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G; Lohmander S; Sachs C
    Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary excretion of 3-methoxy-4-hydroxyphenylglycol sulfate in rats after intraventricular injection of 6-OHDA.
    Bareggi SR; Marc V; Morselli PL
    Brain Res; 1974 Jul; 75(1):177-80. PubMed ID: 4842814
    [No Abstract]   [Full Text] [Related]  

  • 17. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat.
    Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():146-54. PubMed ID: 25445479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 6-hydroxydopamine and reserpine on amphetamine-induced release of norepinephrine in rat cerebral cortex.
    Kalisker A; Waymire JC; Rutledge CO
    J Pharmacol Exp Ther; 1975 Apr; 193(1):64-72. PubMed ID: 237115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intraventricular injections of 6-hydroxydopamine on amine metabolites in rat brain and urine.
    Edwards DJ; Ravitch J; Knopf S; Sedlock ML
    Biochem Pharmacol; 1985 Apr; 34(8):1255-63. PubMed ID: 2581581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitated aggression in the rat following 6-hydroxydopamine administration.
    Eichelman BS; Thoa NB; Ng KY
    Physiol Behav; 1972 Jan; 8(1):1-3. PubMed ID: 4677199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.